Therapeutic effect of vasoactive intestinal peptide in collagen-induced arthritis.
Williams
Richard O
RO
Kennedy Institute of Rheumatology, London, UK.
D000818:Animals; D001169:Arthritis, Experimental / Q000188:drug therapy* / Q000276:immunology; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D007371:Interferon-gamma / Q000378:metabolism; D016753:Interleukin-10 / Q000378:metabolism; D015848:Interleukin-5 / Q000378:metabolism; D008198:Lymph Nodes / Q000166:cytology; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D012720:Severity of Illness Index; D013601:T-Lymphocytes / Q000166:cytology / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
D005765:Gastrointestinal Agents; D015848:Interleukin-5; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D014660:Vasoactive Intestinal Peptide; D007371:Interferon-gamma